SH2D1A mutation analysis for diagnosis of XLP in typical and atypical patients

Human Genetics

Volumn 105, Issue 5, 1999, Pages 501-505

  Yin, Luo ^a   Ferrand, Véronique ^a   Lavoué, Marie France ^a   Hayoz, Daniel ^b   Philippe, Noël ^c   Souillet, Gérard ^c   Seri, Marco ^d   Giacchino, Raffaella ^e   Castagnola, Elio ^e   Hodgson, Shirley ^f   Sylla, Bakary S ^a   Romeo, Giovanni ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c HÔPITAL DEBROUSSE   (France)

^d G GASLINI INSTITUTE   (Italy)

^e Ospitale G Gaslini   (Italy)

^f GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; DNA DETERMINATION; EPSTEIN BARR VIRUS; EXON; FEMALE; GENE MUTATION; HAPLOTYPE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOPROLIFERATIVE DISEASE; MALE; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DOMAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; X CHROMOSOME LINKAGE;

CARRIER PROTEINS; DINUCLEOTIDE REPEATS; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; HAPLOTYPES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE (GENETICS); LYMPHOPROLIFERATIVE DISORDERS; MALE; MUTATION; PEDIGREE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SRC HOMOLOGY DOMAINS; X CHROMOSOME;

HUMAN HERPESVIRUS 4;

EID: 0032757616     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004390051137     Document Type: Article

References (24)

1. Bolino A, Yin L, Seri M, Cusano R, Cinti R, Coffey A, Brooksbank R, Howell G, Bentley D, Davis JR, Lanyi A, Huang D, Stark M, Creaven M, Bjørkhaug L, Heitzmann F, Lamartine J, Gaudi S, Sylla BS, Lenoir GM, Castagnola E, Giacchino R, Porta G, Franco B, Zollo M, Sumegi J, Romeo G (1998) A new candidate region for the positional cloning of the XLP gene. Eur J Hum Genet 6:507-517
2. Brandau O, Shuster V, Veiss M, Strahm B, Hellebrand H, Schendel D, Diemeyer C, Belohradsky BH, Meindl A (1999) EBV negative patients with non Hodgkin Burkitt Lymphoma (NHBL) have mutations in the SH2D1A gene as do patients with X-linked lymphoproliferative disease (XLP). Eur J Hum Genet 7(Supplement 1):SP-069
3. Coffey AJ, Brooksbank RA, Brandau O, Oohashi T, Howell GR, Bye JM, Cahn AP, Durham J, Heath P, Pavitt R, Wilkinson J, Leversha M, Huckle E, Shaw-Smith CJ, Dunham A, Rhodes S, Schuster V, Porta G, Yin L, Serafini P, Sylla B, Zollo M, Franco B, Bolino A, Seri M, Lanyi A, Davis JR, Webster D, Harris A, Lenoir G, St Basile G de, Jones A, Behloradsky BH, Achtz H, Murken J, Faessler R, Sumegi J, Romeo G, Vaudin M, Ross MT, Meindl A, Bentley DR (1998) Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat Genet 20:129-135
4. Fleisher G, Starr S, Koven N, Kamiya H, Douglas SD, Henle W (1982) A non-X-linked syndrome with susceptibility to severe Epstein-Barr virus infections. J Pediatr 100:727-730
5. Grierson H, Skare J, Hawk J, Panza M, Purtillo D(1991) Immunoglobulin class and subclass deficiencies prior to EBV infection in males with X-linked lymphoproliferative disease (XLP). Am J Hum Genet 40:294-297
6. Harrington DS, Weisenburger DD, Purtillo DT (1987) Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer 59:1419-1429
7. Hayoz D, Lenoir GM, Nicole A, Pugin P, Regamey C (1988) X-linked lymphoproliferative syndrome identification of a large family in Switzerland. Am J Med 84:529-534
8. Joncas JH, Ghibu F, Blagdon M, Montplaisir S, Stefanescu I, Menezes J (1984) A familial syndrome of susceptibility to chronic active Epstein-Barr virus infection. Can Med Assoc J 130:280-285
9. Lamartine J, Nichols KE, Yin L, Krainer M, Heitzmann F, Bernard A, Gaudi S, Lenoir GM, Sullivan JL, Ikeda JE, Porta G, Schlessinger D, Romeo G, Haber DA, Sylla BS, Harkin DP (1996) Physical map and cosmid contig encompassing a new interstitial deletion of the X-linked lymphoproliferative syndrome region. Eur J Hum Genet 4:342-351
10. Lanyi A, Li BF Li SB, Talmadge CB, Brichacek B, Davis JR, Kozel BA, Trask B, Engh G van den, Uzvolgyi E, Stanbridge EJ, Nelson DL, Chinault C, Heslop H, Gross TG, Seemayer TA, Klein G, Purtillo DT, Sumegi J (1997) A yeast artificial chromosome (YAC) contig encompassing the critical region of the X-linked lymphoproliferative disease (XLP) locus. Genomics 39:55-65
11. Nichols KE, Harkin DP, Levitz S, Krainer M, Kolquist KA, Genovese C, Bernard A, Ferguson M, Zuo L, Snyder R, Buckler AJ, Wise C, Ashley J, Lovett M, Valentine MB, Look AT, Gerald W, Housman DE, Haber DA (1998) Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc Natl Acad Sci USA 95:13765-13770
12. Purtillo DT, Grierson HL (1991) Methods of detection of new families with X linked lymphoproliferative disease (XLP). Cancer Genet Cytogenet 51:143-153
13. Purtillo DT, Yang JP, Cassel CK, Harper P, Stephenson SR, Landin BH, Vawter GF (1975) X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet I:935-940
14. Purtillo DT, Sakamoto K, Bernabei V, Seeley J, Bechtold T, Rogers G and the XLP collaborators (1982) Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP). Am J Med 73:49-56
15. Sayos J, Wu C, Morra M, Wang N, Zhang X, Allen D, Schaik S van, Notarangelo L, Geha R, Roncarolo MG, Oettgen H, De Vries JE, Aversa G, Terhorst C (1998) The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature 395:462-469
16. Schuster V, Kress W, Friedrich W, Grimm T, Kreth HW (1993) X-linked lymphoproliferative disease: Detection of a paternally inherited mutation in a German family using haplotype analysis. The American Journal of Diseases of Children 147:1303-1305
17. Skare JC, Grierson HL, Sullivan JL, Nusbaum RL, Purtillo DT, Sylla BS, Lenoir GM, Reilly DS, White BN, Milunsky A (1989a) Linkage analysis of seven kindred with the X-linked lymphoproliferative syndrome (XLP) confirms that XLP locus is near DXS42 and DXS37. Hum Genet 82:354-358
18. Skare JC, Grierson H, Wyandt H, Sanger W, Milunsky J, Purtillo D, Sullivan J, Milunsky A (1989b) Genetic of the X-linked lymphoproliferative syndrome. Am J Hum Genet 45:A161
19. Skare J, Wu BL, Madan S, Pulijaal V, Purtilo D, Haber D, Nelson D, Sylla B, Grierson H, Nitowsky H, Glaser J, Wissink J, White B, Holden J, Housman D, Lenoir G, Wyandt H, Milunsky A (1993) Characterization of three overlapping deletions causing X-linked lymphoproliferative disease. Genomics 16: 254-255
20. Sylla BS, Wang Q, Hayoz D, Lathrop GM, Lenoir GM (1989) Multipoint linkage mapping of the Xq25-26 region in a family affected by the X-linked lymphoproliferative syndrome. Clin Genet 36:459-462
21. Sylla BS, Lamartine J, Wang Q, Pauly S, Lenoir GM, Haber D, Skare J, Nelson DL, Romeo G, Tsuji O (1993) Characterization of an XLP patient carrying an interstitial deletion at Xq25. Cytogenet Cell Genet 64:189
22. Tangye SG, Lazetic S, Woollatt E, Sutherland GR, Lanier LL, Phillips JH (1999) Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol 162:6981-6985
23. Yin L, Tocco T, Pauly S, Lenoir GM, Romeo G (1999) Absence of SH2D1A point mutation in 62 Burkitt lymphoma cell lines. The American Journal of Human Genetics 65 (Supplement):A1868
24. Wyandt H, Grierson H, Sanger W, Skare J, Milunsky A, Purtillo D (1989) Chromosome deletion of Xq25 in an individual with X-linked lymphoproliferative disease. Am J Med Genet 33:426-430